118 HR 133 RH: Mandating Exclusive Review of Individual Treatments Act U.S. House of Representatives 2024-12-19 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

IB Union Calendar No. 779 118th CONGRESS2d Session H. R. 133 [Report No. 118–764, Part I] IN THE HOUSE OF REPRESENTATIVES January 9, 2023 Mr. Buchanan (for himself, Ms. Barragán, and Ms. Salazar) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned November 22, 2024 Reported from the Committee on Energy and Commerce with an amendment Strike out all after the enacting clause and insert the part printed in italic November 22, 2024 Referral to the Committee on Ways and Means extended for a period ending not later than December 19, 2024 December 19, 2024 Additional sponsors: Mr. Fitzpatrick, Mr. Ferguson, Mr. Carey and Mrs. Miller of West Virginia December 19, 2024 Committee on Ways and Means discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed For text of introduced bill, see copy of bill as introduced on January 9, 2023 A BILL To amend title XVIII of the Social Security Act to clarify the use of the national coverage determination process under the Medicare program.

1.

Short title

This Act may be cited as the Mandating Exclusive Review of Individual Treatments Act or the MERIT Act.

2.

Clarification on Medicare national coverage determination process

Section 1862(a) of the Social Security Act (42 U.S.C. 1395y(a)) is amended by adding at the end the following new sentence: For purposes of paragraph (1)(E), with respect to a determination made on or after the date of the enactment of this sentence of whether a drug or biological is reasonable and necessary to carry out the purposes of such section, such determination shall be made with respect to each drug or biological involved and not with respect to a class of drugs or biologicals..

December 19, 2024 Committee on Ways and Means discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed